Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE BrokerBank Securities, Inc.
NEW YORK, Feb. 10, 2014 /PRNewswire/ -- Elite Pharmaceuticals Inc. (OTCQB: ELTP) is a specialty pharmaceutical company that is principally engaged in the research, development, and the licensing of proprietary controlled-release drug delivery systems and products. Elite Pharmaceuticals was founded in 1984 and is headquartered in Northvale, New Jersey.
The company develops orally administered controlled-release products for various therapeutic conditions, including pain, allergy, and infection. In addition, Elite Pharmaceuticals has a portfolio of generic drug candidates under development and is developing abuse resistant opioid products, and once-daily opioid products. The company also engages in contract research and development on behalf of other pharmaceutical companies.
Recent studies have shown that the global pharmaceuticals market grew by 3.5% in 2011 to reach a total value of $782.1 Billion. This trend is expected to increase and by 2016 the global pharmaceuticals market is expected to have a total value of $971.1 Billion, which represents an increase of 24.2% over the value in 2011. The market is characterized by strong buyer power, and the ease of market entry is strongly affected by the level of legal and regulatory factors present in each jurisdiction and geographical region.
Elite Pharmaceuticals may be the next company to capture an increasing share of this expanding market. A free and comprehensive analyst research report on ELTP which includes Overview of Global Pharmaceuticals Industry, U.S Food and Drug Administration's (FDA) Approval process, Commercial portfolio, Pipeline Drugs, Value of the Company, Analyst Summary and Price Target can be found here: http://bit.ly/AnalystReportELTP copy and paste to browser may be required
SmallCapStreet.com is the leading source for micro-cap and small-cap stock reports and analysis. We work closely with the very best Chartered Financial Analysts and financial writers in the industry to bring accurate and useful information to the investment community.
For the Stock Profiles Text Keyword "Street" to 25827 to Receive Instant Mobile Alerts
1. BrokerBank Securities, Inc. is the party responsible for issuing the press release. Small Cap Street, LLC is the party responsible for hosting the full analyst report on SmallCapStreet.com. Osman Ghani, Chartered Financial Analyst, is the author of research report.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Osman Ghani, Chartered Financial Analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted to increase awareness to the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at firstname.lastname@example.org.
5. For any urgent concerns or inquiries, please contact us at email@example.com.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Osman Ghani, Chartered Financial Analyst. An outsourced research services provider represented by Osman Ghani, Chartered Financial Analyst, has written and reviewed the information in this article or report. BrokerBank Securities, Inc. or Small Cap Street, LLC is not entitled to veto, interfere or alter the articles, documents or report once created and reviewed by the outsourced research provider represented by Osman Ghani, Chartered Financial Analyst.
NOT FINANCIAL ADVICE
BrokerBank Securities, Inc. or Small Cap Street, LLC makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
EAPH has not compensated BrokerBank Securities, Inc. Small Cap Street, LLC or Osman Ghani, Chartered Financial Analyst, for the creation or dissemination of this press release. BrokerBank Securities, Inc. or Small Cap Street, LLC. is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by BrokerBank Securities, Inc. or Small Cap Street, LLC. whatsoever for any direct, indirect or consequential loss arising from the use of this document. BrokerBank Securities, Inc. or Small Cap Street, LLC. expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. BrokerBank Securities, Inc. or Small Cap Street, LLC. does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
BrokerBank Securities, Inc. is a member of the Financial Industry Regulatory Authority, CRD number #130116.
©2012 PR Newswire. All Rights Reserved.